DSpace@İnönü

Spectroscopy analysis of uterine leiomyomas before and after treatment with GnRH-a

Basit öğe kaydını göster

dc.contributor.author Hasçalık, Şeyma
dc.contributor.author Çelik, Önder
dc.contributor.author Saraç, Kaya
dc.contributor.author Alkan, Alpay
dc.contributor.author Mızrak, Bülent
dc.date.accessioned 2020-06-02T10:37:18Z
dc.date.available 2020-06-02T10:37:18Z
dc.date.issued 2005
dc.identifier.citation Şeyma H., Önder Ç., Kaya S., Alpay A., Bülent M. (2005). Spectroscopy analysis of uterine leiomyomas before and after treatment with GnRH-a, GORM:Gynecology Obstetrics & Reproductive Medicine, GORM:Gynecology Obstetrics & Reproductive Medicine tr_TR
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/15644
dc.description Öz: Başlık (İngilizce): Öz (İngilizce):MR spectroscopy uses the same hardware as magnetic resonance imaging but provides information at the biochemical level. It has been used to measure proton-containing compounds, such as amino acids, fatty acids, organic acids, sugars and other metabolic active compounds in tissue specimens. Before and after GnRH-a treatment we measured lipid, lactate, creatine and choline concentrations in two patients with uterine leiomyomas using single-voxel proton MR spectroscopy. Subcutaneous goserelin acetate injection was performed at least two times every 4 weeks before surgery. Spectroscopy was performed 3 weeks later last goserelin acetate injection. The MR spectroscopy results of leiomyomas before and after GnRH-a treatment were compared. Before GnRH-a treatment, spectral analysis of each patients showed only choline signals. After GnRH-a treatment, spectrum of both patients showed lipid peaks but the other signals were not observed. The presence of lipid signals and absence of other signals suggest a diffuse metabolic defect in association with GnRHa treatment, possibly consistent with decrease in myoflaments, and increase in apopitosis and necrosis. tr_TR
dc.description.abstract Öz: Başlık (İngilizce): Öz (İngilizce):MR spectroscopy uses the same hardware as magnetic resonance imaging but provides information at the biochemical level. It has been used to measure proton-containing compounds, such as amino acids, fatty acids, organic acids, sugars and other metabolic active compounds in tissue specimens. Before and after GnRH-a treatment we measured lipid, lactate, creatine and choline concentrations in two patients with uterine leiomyomas using single-voxel proton MR spectroscopy. Subcutaneous goserelin acetate injection was performed at least two times every 4 weeks before surgery. Spectroscopy was performed 3 weeks later last goserelin acetate injection. The MR spectroscopy results of leiomyomas before and after GnRH-a treatment were compared. Before GnRH-a treatment, spectral analysis of each patients showed only choline signals. After GnRH-a treatment, spectrum of both patients showed lipid peaks but the other signals were not observed. The presence of lipid signals and absence of other signals suggest a diffuse metabolic defect in association with GnRHa treatment, possibly consistent with decrease in myoflaments, and increase in apopitosis and necrosis. tr_TR
dc.language.iso tr tr_TR
dc.publisher GORM:Gynecology Obstetrics & Reproductive Medicine tr_TR
dc.subject Kadın Hastalıkları ve Doğum tr_TR
dc.title Spectroscopy analysis of uterine leiomyomas before and after treatment with GnRH-a tr_TR
dc.type Article tr_TR


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster